PDF
Word
Form F-02505 Prior Authorization Drug Attachment for Lipotropics, Proprotein Convertase Subtilisin / Kexin Type 9 (Pcsk9) Inhibitors - Wisconsin
What Is Form F-02505?
This is a legal form that was released by the Wisconsin Department of Health Services - a government authority operating within Wisconsin. Check the official instructions before completing and submitting the form.
FAQ
Q: What is Form F-02505?
A: Form F-02505 is a Prior Authorization Drug Attachment for Lipotropics, Proprotein Convertase Subtilisin/Kexin Type 9 (Pcsk9) Inhibitors in Wisconsin.
Q: What is the purpose of Form F-02505?
A: Form F-02505 is used to request prior authorization for Lipotropics, Proprotein Convertase Subtilisin/Kexin Type 9 (Pcsk9) Inhibitors.
Q: Who needs to use Form F-02505?
A: Healthcare providers prescribing Lipotropics, Proprotein Convertase Subtilisin/Kexin Type 9 (Pcsk9) Inhibitors in Wisconsin need to use Form F-02505.
Q: What are Lipotropics?
A: Lipotropics are drugs that help in the breakdown and metabolism of fats in the body.
Q: What are Proprotein Convertase Subtilisin/Kexin Type 9 (Pcsk9) Inhibitors?
A: Proprotein Convertase Subtilisin/Kexin Type 9 (Pcsk9) Inhibitors are drugs used to lower cholesterol levels in patients who have a high risk of cardiovascular events.
Form Details:
- Released on July 1, 2019;
- The latest edition provided by the Wisconsin Department of Health Services;
- Easy to use and ready to print;
- Quick to customize;
- Compatible with most PDF-viewing applications;
- Fill out the form in our online filing application.
Download a fillable version of Form F-02505 by clicking the link below or browse more documents and templates provided by the Wisconsin Department of Health Services.
Download Form F-02505 Prior Authorization Drug Attachment for Lipotropics, Proprotein Convertase Subtilisin / Kexin Type 9 (Pcsk9) Inhibitors - Wisconsin
1
2
3
